BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM)
Jl. Harousseau et al., BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM), Blood, 90(10), 1997, pp. 1018-1018